News & Insights
July 1, 2020 •
Blog
Read More
Pre-IND Meeting Requests for COVID-19 Products
Given the numerous inquiries from prospective sponsors interested in conducting clinical trials for COVID-19 products, FDA has issued new guidance to assist sponsors in preparing Type B pre-investigational new drug application (pre-IND) meeting requests for COVID-19 related drugs and biologics1. This…